Genetic Technologies Posts $1.6M in Revenues in Q2 | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Australian genetic test company Genetic Technologies said on Monday that it posted A$1.5 million (US$1.6 million) in revenues for its fiscal second quarter.

The company had no reported R&D spending during the quarter ended Dec. 31, 2011. Advertising and marketing expenses came in at A$92,651.

Genetic Technologies said it had a net loss of A$2.2 million and ended the quarter with A$12.6 million in cash.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.